Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
New to Comunitee?

or Sign Up with Email



NOV 04, 2013 - Yahoo! News

A Must Read - Share

Teva asks U.S. justices for stay in Copaxone case

By Lawrence Hurley WASHINGTON (Reuters) - Teva Pharmaceutical Industries on Monday asked the U.S. Supreme Court to stay an appeals court ruling that would strip its $4 billion-a-year multiple sclerosis drug Copaxone of its patent protection in 2014 rather than 2015. In July, the U.S. Court of Appeals for the Federal Circuit issued its decision in a patent fight that pits Teva against two teams developing cheaper generic forms of Copaxone: one with Novartis AG and Momenta Pharmaceuticals Inc and another between Mylan Inc and Natco Pharma Ltd. The appeals court upheld some of nine patents ... Read More

Tags: Teva asks U.S. justices for stay in Copaxone case,  Multiple Sclerosis Latest News